The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of CN201, a novel CD3xCD19 IgG4 bispecific antibody, in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia.
 
Ying Wang
No Relationships to Disclose
 
Qingsong Yin
No Relationships to Disclose
 
Jinhai Ren
No Relationships to Disclose
 
Hongsheng Zhou
No Relationships to Disclose
 
Tiejun Gong
No Relationships to Disclose
 
Feng Zhu
No Relationships to Disclose
 
Xi Zhang
No Relationships to Disclose
 
Qin Wen
No Relationships to Disclose
 
Heng Mei
No Relationships to Disclose
 
Wei Huang
No Relationships to Disclose
 
Haiying Li
Employment - Curon Biopharmaceutical
Stock and Other Ownership Interests - Curon Biopharmaceutical
 
Jianxiang Wang
Consulting or Advisory Role - Abbvie